Viewing Study NCT04840394


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-31 @ 4:10 PM
Study NCT ID: NCT04840394
Status: COMPLETED
Last Update Posted: 2025-11-12
First Post: 2021-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Sponsor: Eikon Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module